Barclays
NUS icon

Barclays’s Nu Skin NUS Stock Holding History

Barclays’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,700
Closed -$190K – 6052
2020
Q1 		$190K Buy
8,700
+6,500
+295% +$196K ﹤0.01% 4340
2019
Q4 		$90K Sell
2,200
-300
-12% -$12.2K ﹤0.01% 5526
2019
Q3 		$106K Buy
2,500
+900
+56% +$37.8K ﹤0.01% 5438
2019
Q2 		$79K Sell
1,600
-1,200
-43% -$61K ﹤0.01% 5855
2019
Q1 		$134K Sell
2,800
-8,400
-75% -$509K ﹤0.01% 5126
2018
Q4 		$687K Buy
11,200
+8,000
+250% +$540K ﹤0.01% 3503
2018
Q3 		$264K Buy
3,200
+100
+3% +$7.95K ﹤0.01% 4774
2018
Q2 		$242K Buy
3,100
+1,600
+107% +$124K ﹤0.01% 4554
2018
Q1 		$111K Sell
1,500
-124,100
-99% -$8.81M ﹤0.01% 5311
2017
Q4 		$8.57M Buy
125,600
+100
+0.1% +$6.47K 0.01% 1270
2017
Q3 		$7.72M Buy
125,500
+3,500
+3% +$215K 0.01% 1211
2017
Q2 		$7.67M Buy
122,000
+121,000
+12,100% +$6.9M 0.01% 1155
2017
Q1 		$56K Sell
1,000
-17,900
-95% -$922K ﹤0.01% 5277
2016
Q4 		$903K Sell
18,900
-15,100
-44% -$846K ﹤0.01% 2848
2016
Q3 		$2.2M Buy
34,000
+18,600
+121% +$1.05M ﹤0.01% 1924
2016
Q2 		$711K Sell
15,400
-8,200
-35% -$330K ﹤0.01% 2902
2016
Q1 		$897K Sell
23,600
-7,000
-23% -$232K ﹤0.01% 2613
2015
Q4 		$1.13M Buy
30,600
+2,100
+7% +$77.4K ﹤0.01% 2499
2015
Q3 		$1.17M Sell
28,500
-14,200
-33% -$610K ﹤0.01% 2564
2015
Q2 		$2.01M Sell
42,700
-20,400
-32% -$1.1M ﹤0.01% 2220
2015
Q1 		$3.79M Sell
63,100
-16,600
-21% -$845K ﹤0.01% 1778
2014
Q4 		$3.43M Buy
79,700
+23,100
+41% +$1.02M ﹤0.01% 2030
2014
Q3 		$2.55M Sell
56,600
-18,400
-25% -$979K ﹤0.01% 2434
2014
Q2 		$5.47M Sell
75,000
-3,700
-5% -$292K 0.01% 1657
2014
Q1 		$6.45M Buy
78,700
+50,600
+180% +$4.44M 0.01% 1509
2013
Q4 		$3.88M Buy
28,100
+6,200
+28% +$730K ﹤0.01% 2036
2013
Q3 		$2.08M Buy
21,900
+10,100
+86% +$857K ﹤0.01% 2530
2013
Q2 		$721K Buy
+11,800
New +$655K ﹤0.01% 3779

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Barclays's NUS Position: Q1 2026 in Review

Barclays reduced its Nu Skin (NUS) stake by 44% in Q1 2026, selling an estimated $565K and leaving 78,860 shares worth $574K. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

Barclays first reported a position in NUS in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.6M in Q2 2019. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • Barclays held 78,860 shares of Nu Skin worth $574K as of Q1 2026.
  • Barclays sold 62,376 Nu Skin shares in Q1 2026, an estimated $565K.
  • Nu Skin made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3106 holding.
  • Barclays first reported a position in Nu Skin in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Nu Skin position peaked at $13.6M in Q2 2019.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.